NCT00818038View on ClinicalTrials.gov

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

BG0002 (natalizumab)

Participants who are newly prescribed TYSABRI, but have not received their first infusion, will be invited to participate.

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY